Investigation of the possibility of using ischemia-modified albumin as a novel and early prognostic marker in cardiac arrest patients after cardiopulmonary resuscitation

Creative Commons License

Türedi S., Gündüz A., Menteşe A., Dasdibi B., Karahan S. C., Sahin A., ...More

RESUSCITATION, vol.80, no.9, pp.994-999, 2009 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 80 Issue: 9
  • Publication Date: 2009
  • Doi Number: 10.1016/j.resuscitation.2009.06.007
  • Journal Name: RESUSCITATION
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.994-999
  • Keywords: Ischemia-modified albumin, Ischemia, Cardiac arrest, Cardiopulmonary resuscitation, Oxidative stress, NEURON-SPECIFIC ENOLASE, PULMONARY-EMBOLISM, OXIDATIVE STRESS, SERUM, DIAGNOSIS, HYPOTHERMIA, PREDICTION, PROTEIN, S-100, COMA
  • Karadeniz Technical University Affiliated: Yes


Background: Early and accurate prediction of survival to hospital discharge following resuscitation after cardiac arrest (CA) is a major challenge. Our aim was to investigate the levels of ischemia-modified albumin (IMA) and malondialdehyde (MDA) in CA patients and whether IMA levels are valuable early marker of post-cardiopulmonary resuscitation prognosis in CA patients.